Idhifa
Active substance: enasidenib
TABLET, FILM COATED · ENASIDENIB MESYLATE 50 mg/1
United StatesActive
Marketing holder: Celgene Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ENASIDENIB MESYLATE · 50 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12096-6cf6-7e85-b9df-8080bbdbb3cf,01a1209b-57f8-74a9-b448-625c8229684a;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59572-705
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59572-705 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59572-705 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59572-705 · Verified 2026-10-09 · open in source